RA-18C3
RA-18C3 Uses, Dosage, Side Effects, Food Interaction and all others data.
RA-18C3 is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).
| Trade Name | RA-18C3 |
| Generic | Bermekimab |
| Bermekimab Other Names | Bermekimab, RA-18C3 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here RA-18C3
